|
業務類別
|
Biotechnology |
|
業務概覽
|
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States. |
| 公司地址
| 5217 Winnebago Lane, Austin, TX, USA, 78744 |
| 電話號碼
| +1 512 386-2900 |
| 傳真號碼
| +1 512 386-5505 |
| 公司網頁
| http://www.xbiotech.com |
| 員工數量
| 92 |
| Ms. Angela Hu |
Director of Finance, Principal Financial Officer and Principal Accounting Officer |
美元 200.00K |
07/07/2025 |
| Ms. Sushma Shivaswamy |
Chief Scientific Officer and Interim Chief Executive Officer |
美元 450.00K |
09/12/2025 |
|
|
| Dr. Tevi David Troy, M.A. |
Independent Director |
02/09/2025 |
| Dr. Thomas Kundig |
Director |
24/06/2025 |
| Dr. David Spencer Soffer |
Independent Director |
02/09/2025 |
| Mr. Craig Evan Rademaker |
Director |
24/06/2025 |
| Mr. John Simard |
Chairman of the Board |
09/12/2025 |
| Mr. Jan-Paul Waldin, Esq. |
Lead Independent Director |
07/07/2025 |
| Dr. Peter Libby, M.D. |
Independent Director |
07/07/2025 |
| Dr. Tak W. Mak |
Director |
07/07/2025 |
|
|
|
|
